IonQ Stock: Buy the Dip?
Summary
Parkev highlights IonQ's exceptional financial performance, noting a 336% year-over-year revenue surge to $17.4 million. Parkev explains that while the stock price has faced pressure due to bottom-line losses and share dilution, the company's fundamentals are improving. Management has already sold out manufacturing capacity for 2027, and the acquisition of SkyWater has significantly bolstered revenue. Parkev also points to the achievement of the DARPA Stage C milestone, which could provide up to $300 million in government grants for research and development.
From a valuation perspective, Parkev notes that the forward price-to-sales ratio has dropped from a peak of 90 to a much more reasonable 16.7. Parkev emphasizes that the company's operating cash flow relative to revenue is trending in the right direction, improving from -375% to -170%. While Parkev acknowledges that quantum computing is one of the riskiest sectors in the market, Parkev believes the current price offers a significant margin of safety for speculative investors.
Mentioned Stocks
Reasoning: Parkev rates IonQ as a buy because his discounted cash flow model estimates a fair value of $54, which is well above the current market price of $35. Parkev is impressed by the 336% revenue growth, the achievement of DARPA technical milestones, and the strengthened balance sheet with $3.7 billion in cash. Although it remains a high-risk speculative play, Parkev believes the current valuation (16.7x forward P/S) is much more attractive than previous peaks.